Advanced Biomed Inc. (ADVB) is a medical-technology company that develops microfluidic biochip technologies and precision cancer-diagnosis and treatment applications through its subsidiaries. By combining semiconductor and biotechnology methods, it has created systems for cancer screening, detection, diagnosis, staging, and treatment support. Devices include A+Pre, AC-1000, A+CellScan, and A+SCDrop, supported by A+Pre, AC-1000 CTC Enrichment, and A+CellScan microfluidic chips, with the goal of providing rapid and affordable assays for cancer patients.

ADVB Net Money Flow History